Compugen (CGEN) Gross Profit Growth (1y) (2010 - 2026)
Compugen (CGEN) Gross Profit Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 41.37% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 7.76% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 16.94% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 66.01% |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Compugen | 215.59 Mn | 123.84 Mn | 352,000.00 | 403.45% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 403.45% |
| Dec 31, 2025 | -99.99% |
| Sep 30, 2025 | -98.22% |
| Jun 30, 2025 | -107.92% |
| Mar 31, 2025 | -125.38% |
| Dec 31, 2024 | -97.47% |
| Dec 31, 2023 | 382.07% |
| Dec 31, 2016 | 247,254.68% |
| Sep 30, 2016 | 75.00% |
| Jun 30, 2016 | 446.67% |
| Mar 31, 2016 | -90.84% |
| Dec 31, 2015 | 30.76% |
| Sep 30, 2015 | -97.13% |
| Jun 30, 2015 | -93.21% |
| Mar 31, 2015 | -90.48% |
| Dec 31, 2014 | 476.68% |
| Sep 30, 2014 | 681.60% |
| Jun 30, 2014 | 1,882.26% |
| Mar 31, 2014 | 11,366.67% |
| Dec 31, 2013 | 2,938.24% |